Medtrum Drug Delivery System with Graphical User Interface

ChangeBridge: Patent Apps - Medical Devices (A61M)

Published April 2nd, 2026

Detected April 2nd, 2026

Summary

The USPTO published patent application US20260091175A1 by Medtrum Technologies Inc. covering a drug delivery system with graphical user interface for insulin infusion and blood glucose monitoring. The system includes a detection device, infusion device, and control device with GUI displaying insulin infusion status and blood glucose information. Filing date was September 13, 2022.

View original document View source feed page

What changed

Medtrum Technologies Inc. filed patent application US20260091175A1 for a drug delivery system integrating blood glucose detection and insulin infusion with a graphical user interface. The system comprises three components: a detection device for measuring blood glucose, an infusion device for delivering insulin, and a control device with GUI that displays insulin infusion status and blood glucose data in both graphical and textual formats. CPC classifications include A61M 5/1723, A61M 5/14244, and G16H 20/17.

This is a patent application publication with no compliance obligations or regulatory requirements. No action is required by regulated entities. Patent applications do not create binding obligations and are informational only for competitive intelligence purposes.

Source document (simplified)

← USPTO Patent Applications

DRUG DELIVERY SYSTEM WITH GRAPHICAL USER INTERFACE

Application US20260091175A1 Kind: A1 Apr 02, 2026

Assignee

MEDTRUM TECHNOLOGIES INC.

Inventors

Cuijun Yang

Abstract

The invention discloses a drug delivery system with graphical user interface comprises a detection device, for detecting the blood glucose level of the user; an infusion device, for infusing a drug into the user's body; and a control device, wirelessly communicated with the detection device and the infusion device, the control device controlling the drug delivery of the infusion device, and the control device provided with a graphical user interface, the graphical user interface comprising a main screen, the main screen comprising an insulin information display area and a blood glucose information display area, wherein the insulin information display area comprising insulin infusion status information, the graphical user interface displays the insulin infusion status information in a graphical and/or textual manner, to facilitate the user to intuitively know the insulin infusion status information and blood glucose information at that time.